bevacizumab Injection

Brand(s)
Avastin
Category(s)
prescription
SPL Type(s)
Human Prescription
Master SPL
Genentech, Inc. (2015-10-20)
Oldest Current Product
2004-02-26
License(s)
BLA
RxNORM
INJECTION\BEVACIZUMAB
SPL Active
INTRAVENOUS\INJECTION, SOLUTION\BEVACIZUMAB
SPL Moiety
INTRAVENOUS\INJECTION, SOLUTION\BEVACIZUMAB

product(s) by strength(s)

4 ml bevacizumab 25 mg/ml injection

original product(s)(s)

#idbrandcategorylabelerfirst marketedactive ingredient(s)routedose formapplicationspl
1502420060AvastinBLAGenentech, Inc.2004-02-26BEVACIZUMABINTRAVENOUSINJECTION, SOLUTION125085939b5d1f-9fb2-4499-80ef-0607aa6b114e

16 ml bevacizumab 25 mg/ml injection

original product(s)(s)

#idbrandcategorylabelerfirst marketedactive ingredient(s)routedose formapplicationspl
1502420061AvastinBLAGenentech, Inc.2004-02-26BEVACIZUMABINTRAVENOUSINJECTION, SOLUTION125085939b5d1f-9fb2-4499-80ef-0607aa6b114e

application(s)

#idtitleapprovedtradenamesfda division
1125085bevacizumab Application2004-02-26AvastinCDER

spl(s)

#idtitlecategorytypelabelerlabeler actlast updateversionproduct(s)
1939b5d1f-9fb2-4499-80ef-0607aa6b114e (view SPL)These highlights do not include all the information needed to use AVASTIN safely and effectively. See full prescribing information for AVASTIN. AVASTIN (bevacizumab)Solution for intravenous infusionInitial U.S. Approval: 2004prescriptionHuman PrescriptionGenentech, Inc.ANALYSIS, API MANUFACTURE, LABEL, MANUFACTURE, PACK2015-10-2021502420060, 502420061

Data from: FDAOB, FDAPB, LOINC, MTHSPL, NDFRT, NCIT, RxNORM, UNII